Shanghai Haohai Biological Technology Co., Ltd.

   
Haohai Vision is the core ophthalmic business segment of

Shanghai Haohai Biological Technology Co., Ltd.

— the first biomedical company listed on both STAR Market (688366) and Hong Kong Stock Exchange (06826).

We are committed to providing comprehensive eye health solutions for global patients across the full eye care lifecycle, shaping a new future for the ophthalmic industry.

With 18 years of focus since 2007, we have built a complete industrial chain covering raw materials, R&D, manufacturing and distribution.

Today, Haohai Vision is: